At the same time, an improved proportion of n-3 PUFAs and SAFAs in the cell membrane decreases CHD mortality by diminishing the proportion of PIMs in adipose tissue, slowing down the production of TNF-α and inflammatory interleukins with a beneficial effect on the arterial wall. The gene discussed is TNF; the disease is coronary artery disorder.